Device Trial Radar · NCT06112093
Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Oct 23, 2023
Primary completion
Oct 23, 2028
Study completion Oct 23, 2028
Sponsor
- Lead sponsor
- State University of New York - Upstate Medical UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 1, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.
Conditions
- Brain Concussion
- Mild Traumatic Brain Injury
- Headache
- Post-Concussion Symptoms
Interventions
Repetitive Transcranial Magnetic StimulationDevice
rTMS will be used to regulate the motor cortex to reduce headaches and post-concussion symptoms.
Sham Repetitive Transcranial Magnetic StimulationDevice
Sham rTMS will be delivered by a sham coil as a comparator to the (active) rTMS. Sham rTMS will not change the brain function of the control group.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Daily headache diaryTime frame: daily documentation throughout the treatment course (4 weeks)
- Patient-Reported Outcomes Measurement Information System (PROMIS)Time frame: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up
- Protein expressionTime frame: baseline, immediately post-treatment (completion of rTMS)
5 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
SUNY Upstate Medical University
Syracuse, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.